Stay updated on CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial
Sign up to get notified when there's something new on the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page.

Latest updates to the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page
- CheckyesterdayChange DetectedThe page’s revision label has been updated to v3.6.4 from v3.6.3, indicating a small backend or front-end update. It does not alter the study details or how users interact with the page.SummaryDifference0.0%

- Check8 days agoChange DetectedThe page no longer displays related-topic links for schizophrenia and MedlinePlus Genetics, reducing cross-links to those resources and affecting navigation rather than the trial details.SummaryDifference0.1%

- Check16 days agoChange DetectedAdded Schizophrenia and MedlinePlus Genetics to the page's related topics section, updating the related topics navigation. This reflects a refinement of linked topics associated with the study page.SummaryDifference0.1%

- Check23 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, representing a small update to the page's documentation/versioning rather than a substantive change to the study record.SummaryDifference0.0%

- Check30 days agoChange DetectedThe page now shows a new Revision: v3.6.2 tag and the topic links for Schizophrenia and MedlinePlus Genetics were removed from the related topics section.SummaryDifference0.2%

- Check37 days agoChange DetectedAdds a related topics section with Schizophrenia and MedlinePlus Genetics to the study page, linking the trial to its disease context and a genetics information resource.SummaryDifference0.1%

Stay in the know with updates to CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page.